188 related articles for article (PubMed ID: 2995969)
1. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
2. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin.
Matsuura H; Greene T; Hakomori S
J Biol Chem; 1989 Jun; 264(18):10472-6. PubMed ID: 2471705
[TBL] [Abstract][Full Text] [Related]
3. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
Matsuura H; Takio K; Titani K; Greene T; Levery SB; Salyan ME; Hakomori S
J Biol Chem; 1988 Mar; 263(7):3314-22. PubMed ID: 2449438
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site.
Feinberg RF; Kliman HJ; Bedian V; Monzon-Bordonaba F; Menzin AW; Wang CL
Am J Obstet Gynecol; 1995 May; 172(5):1526-36. PubMed ID: 7538728
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
6. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Kaczmarek J; Castellani P; Nicolo G; Spina B; Allemanni G; Zardi L
Int J Cancer; 1994 Oct; 59(1):11-6. PubMed ID: 7927891
[TBL] [Abstract][Full Text] [Related]
7. Synthetic immunochemistry of glycohexapeptide analogues characteristic of oncofetal fibronectin. Solid-phase synthesis and antigenic activity.
Zheng M; Gobbo M; Biondi L; Filira F; Hakomori S; Rocchi R
Int J Pept Protein Res; 1994 Mar; 43(3):230-8. PubMed ID: 8005745
[TBL] [Abstract][Full Text] [Related]
8. Expression of a developmentally regulated epitope on fibronectins from the synovial fluid of patients with rheumatic disease.
Carsons S; Clausen H; Wolf J
J Rheumatol; 1994 Oct; 21(10):1888-91. PubMed ID: 7530772
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues.
Borsi L; Balza E; Allemanni G; Zardi L
Exp Cell Res; 1992 Mar; 199(1):98-105. PubMed ID: 1310473
[TBL] [Abstract][Full Text] [Related]
10. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
11. Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies.
Sekiguchi K; Siri A; Zardi L; Hakomori S
J Biol Chem; 1985 Apr; 260(8):5105-14. PubMed ID: 3988746
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: a caveat for cervicovaginal oncofetal fibronectin testing?
Feinberg RF; Wang CL
Am J Obstet Gynecol; 1994 Nov; 171(5):1302-8. PubMed ID: 7977538
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries.
Farnoud MR; Farhadian F; Samuel JL; Derome P; Peillon F; Li JY
Int J Cancer; 1995 Mar; 61(1):27-34. PubMed ID: 7705930
[TBL] [Abstract][Full Text] [Related]
14. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.
Carnemolla B; Balza E; Siri A; Zardi L; Nicotra MR; Bigotti A; Natali PG
J Cell Biol; 1989 Mar; 108(3):1139-48. PubMed ID: 2646306
[TBL] [Abstract][Full Text] [Related]
15. Expression of oncofetal fibronectin in porcine conceptuses and uterus throughout gestation.
Tuo W; Bazer FW
Reprod Fertil Dev; 1996; 8(8):1207-13. PubMed ID: 8981646
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody defining fibroblasts appearing in fetal and neoplastic tissues.
Bartal AH; Lichtig C; Cardo CC; Feit C; Robinson E; Hirshaut Y
J Natl Cancer Inst; 1986 Mar; 76(3):415-21. PubMed ID: 3456459
[TBL] [Abstract][Full Text] [Related]
17. [Reliability of the detection of fetal fibronectin using monoclonal antibody FDC-6].
Pütz I; Winkler M; Rath W
Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):703-6. PubMed ID: 8582591
[TBL] [Abstract][Full Text] [Related]
18. Expression of the alternatively spliced EIIIB segment of fibronectin.
Peters JH; Trevithick JE; Johnson P; Hynes RO
Cell Adhes Commun; 1995 Feb; 3(1):67-89. PubMed ID: 7538416
[TBL] [Abstract][Full Text] [Related]
19. Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer.
Nicolò G; Salvi S; Oliveri G; Borsi L; Castellani P; Zardi L
Cell Differ Dev; 1990 Dec; 32(3):401-8. PubMed ID: 1711919
[TBL] [Abstract][Full Text] [Related]
20. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L
Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
